Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Mind over matter: imagined walk may predict real falls

NCT ID NCT04039841

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether the difference between how long it takes someone to actually perform a 'get up and walk' test versus how long they imagine it takes can predict future falls. Researchers followed 67 osteoporosis patients for a year after the tests. The goal was to see if a mismatch between real and imagined timing could identify those at higher risk of falling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

67 people

The number who actually took part.

Started

Jul 2019

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 85 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who have been screened for osteoporosis at CHD (aged 50 to 85 years) * Proven presence of osteoporotic risk (positive response to screening tests), * No lower limb fractures making walking impossible, * Realization of iTUG and rTUG. * No objection to the collection and analysis of personal data collected, * Patient can be followed during the study period (12 months), * Patient followed by a treating physician and having given his or her consent for him or her to be contacted as part of the study. Exclusion Criteria: * Insane patient * Deaf patient * Complete blind patient * Patient unable to express himself * Patient at the end of life * Patient already treated for osteoporosis or recent DXA less than 3 years old at the time of screening * Patient who has not been screened for osteoporosis at the CHD * Presence of equipment (e.g. infusion) making it impossible to walk or rendering the reliability of TUGs obsolete,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fall patients are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHD Vendée

    La Roche-sur-Yon, 85000, France

  • Centre Hospitalier Departemental

    La Roche-sur-Yon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.